drugset / Trial / NCT05187403
A Study of Laquinimod Eye-drops in Healthy Participants
RandomizedSequentialTriple-blindTreatment
Summary
This is a Phase 1 randomized, double-masked, placebo-controlled study performed with healthy participants to assess the safety and tolerability of laquinimod eye-drops.
Timeline
- Start
- 2021-12-09
- Primary completion
- 2023-01-19
- Completion
- 2023-01-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Laquinimod | Small molecule | — | Other |